title: Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA.
abstract: Cancer stem cell (CSC) population in solid human breast tumor was identified by CD44(+)/CD24(-) phenotype, characterized by high tumorigenicity, invasiveness and drug resistance. In this study, we characterized drug resistant breast cancer cell line-MCF-7/Adr and a number of breast cancer cell lines using flow cytometry, immunofluorescence, mammosphere formation assay and migration assay, examining their CSC immunophenotypes, presence of CSC proteins, tumorigenicity in vitro and migratory rates, respectively. Our results show that MCF-7/Adr cells uniformly display CSC characteristics yet retain low migratory rate. They are also able to self-renew and differentiate under floating culture conditions. Furthermore, MCF-7/Adr is selectively sensitive to epigenetic drug, suberoylanilide hydroxamic acid (SAHA), losing drug resistance and changes morphology yet retaining CSC immunophenotypes. In conclusion, we show that resistant breast cancer cell line MCF-7/Adr demonstrates uniform CSC like characteristics and are sensitive to epigenetic drug treatment.
authors.affiliation: Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, 44195 ; University of Akron, Integrated Bioscience Program, Akron, Ohio, 44325.
authors.forename: Shan
authors.initials: S
authors.lastname: Lu
authors.forename: Vinod
authors.initials: V
authors.lastname: Labhasetwar
keywords: Breast Cancer Stem Cell; Cancer Therapy; Drug Resistance; Epigenetic Therapy; Epithelial Mesenchymal Transition; Surface Markers
references.citation: Breast Cancer Res. 2008;10(3):R53
references.pmid: 18559090
references.citation: Breast Cancer Res. 2006;8(5):R59
references.pmid: 17062128
references.citation: Breast Cancer Res Treat. 2012 Feb;132(1):75-85
references.pmid: 21553120
references.citation: Cancer Res. 2009 Jul 15;69(14):5820-8
references.pmid: 19584296
references.citation: Blood. 1983 Jul;62(1):1-13
references.pmid: 6407542
references.citation: Nature. 2003 May 15;423(6937):231-3
references.pmid: 12748623
references.citation: Cancer Res. 2008 Jul 15;68(14):5533-9
references.pmid: 18632604
references.citation: Blood. 1986 Dec;68(6):1185-95
references.pmid: 3535923
references.citation: Nat Genet. 2009 Nov;41(11):1238-42
references.pmid: 19801978
references.citation: Lab Invest. 2009 Aug;89(8):857-66
references.pmid: 19488035
references.citation: Pathol Res Pract. 2010 Dec 15;206(12):828-34
references.pmid: 20977976
references.citation: Breast Cancer Res. 2008;10(2):R25
references.pmid: 18366788
references.citation: Cell. 2007 Nov 30;131(5):861-72
references.pmid: 18035408
references.citation: Hum Pathol. 2008 Jul;39(7):1096-102
references.pmid: 18495204
references.citation: J Natl Cancer Inst. 2007 Oct 3;99(19):1435-40
references.pmid: 17895479
references.citation: Cell. 2006 Aug 25;126(4):663-76
references.pmid: 16904174
references.citation: J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85
references.pmid: 17179479
references.citation: J Natl Cancer Inst. 2008 May 7;100(9):672-9
references.pmid: 18445819
references.citation: Clin Exp Metastasis. 2008;25(6):629-42
references.pmid: 18461285
references.citation: Cancer Lett. 2010 Jun 28;292(2):215-27
references.pmid: 20060208
references.citation: Biomed Pharmacother. 2011 Feb;65(1):40-5
references.pmid: 21177063
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Science. 2007 Jul 20;317(5836):337
references.pmid: 17641192
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3547-9
references.pmid: 12657737
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2813-20
references.pmid: 18539959
references.citation: Cancer Res. 2004 Aug 15;64(16):5818-24
references.pmid: 15313925
references.citation: Cancer Res. 2005 Dec 1;65(23):10783-93
references.pmid: 16322224
references.citation: Breast Cancer Res. 2008;10(5):110
references.pmid: 18828879
references.citation: Breast Cancer Res. 2008;10(4):210
references.pmid: 18671830
references.citation: Surg Oncol. 2010 Mar;19(1):27-32
references.pmid: 19251410
references.citation: BMC Cancer. 2009 Jun 25;9:202
references.pmid: 19555472
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):1154-9
references.pmid: 15709183